"Reviving" Life on a Computer: The First Complete 4D Full-Cycle Simulation of a Minimal Genome Cell
Release time:
2026-03-24
To truly understand the principles governing cellular life, it is essential to grasp its complete quantitative characteristics across time and space, as well as the coordination mechanisms of its internal chemical and physical processes. In the past, scientists could only capture a snapshot of a cell at a given moment through a single experiment. Even with the integration of machine learning and artificial intelligence, they could only obtain "snapshots" rather than reconstruct the full picture of life's evolution over time.
On March 9, 2026, a team from the University of Illinois Urbana-Champaign published a paper in Cell, announcing the successful development of the world's first "4D Whole-Cell Model" (4DWCM). This model fully simulates the entire life process—from birth, growth, to division—of JCVI-syn3A, the organism with the smallest known genome on Earth, entirely within a computer. This marks the first time humanity has realistically "driven" a complete life form from the molecular level through its entire life cycle in a virtual environment.
JCVI-syn3A is not a naturally occurring organism but a "minimal life form" created by scientists. With only 493 genes, it divides every 105 minutes like a normal bacterium and maintains a regular spherical shape. In comparison, E. coli has approximately 4,000 genes, making JCVI-syn3A an ideal subject for studying the "minimum configuration" of life.
The research team employed a "hybrid simulation" super-algorithm, dividing the interior of the cell into multiple computational modules:
-
Reaction-diffusion master equation: Tracks the diffusion and interactions of proteins and RNA in three-dimensional space.
-
Brownian dynamics: Simulates the bending, stretching, and separation of chromosomes.
-
Ordinary differential equations: Calculates glucose metabolism and the synthesis of raw materials.
-
Geometric growth model: Updates the shape of the cell membrane in real time to simulate growth and division.
These modules synchronize data every 12.5 milliseconds. Simulating a single cell's lifecycle requires 4 to 6 days of continuous computation on GPUs. The team conducted 50 virtual experiments to ensure statistical reliability.
The model was not built from imagination but was constructed and validated using extensive experimental data: protein quantities were derived from proteomics measurements, morphology was constrained by fluorescence microscopy imaging, and predictions of DNA replication timing closely matched experimental results. Even the copy number ratio at the origin and terminus of chromosome replication was highly consistent between the model's prediction (1.28) and experimental values (1.21).
The simulation also revealed the dual nature of life: the timing of DNA replication initiation varied by tens of minutes among "sibling" cells, reflecting randomness, yet all cells successfully completed division, demonstrating robustness. The distribution of ribosomes and proteins was nearly random, with no two virtual cells being exactly alike—just as real life is unique.
The significance of this 4D model lies in its role as a "digital sandbox" for systems biology: it allows researchers to knock out genes or alter conditions in a virtual environment and quickly observe chain reactions at a cost far lower than that of laboratory experiments. Of course, the model still has limitations, such as not simulating "polyribosome" phenomena and requiring further measurement of certain parameters.
Nonetheless, this newly opened window not only allows us to understand how the simplest form of life operates but also paves the way for simulating more complex human cells in the future.
Latest developments
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
According to the latest announcement from the International Society of Cryobiology, Professor Xu Yi from the School of Health Science and Engineering at the University of Shanghai for Science and Technology, and a member of the Yinfeng Cryomedicine Expert Committee, has been elected as a Board Governor of the Society for a three-year term (2026–2028). The election was conducted through a democratic vote by all members worldwide, with three new Board Governors elected. Professor Xu Yi is the only scholar from Asia elected to the Society’s Board of Governors this time and the third elected scholar from mainland China in the Society’s 60-year history.
The significance of life extension lies not only in technological breakthroughs but also in the shared belief of every individual who believes in "a better future." With faith as their torch, these fellow travelers join hands, pooling their strength to stride forward together. We firmly believe that as this steadfast support converges into a powerful force, it will propel the Yinfeng Life Extension Plan to gain broader attention, inject continuous momentum into the development of cryobiomedicine, and illuminate the next chapter of human civilization.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
